Empirically Defining Treatment Response and Remission in Obsessive-Compulsive Disorder Using the Obsessive-Compulsive Inventory-Revised.

Obsessive-Compulsive Inventory—Revised obsessive-compulsive disorder remission signal detection analysis treatment response

Journal

Behavior therapy
ISSN: 1878-1888
Titre abrégé: Behav Ther
Pays: England
ID NLM: 1251640

Informations de publication

Date de publication:
01 2023
Historique:
received: 28 03 2022
revised: 20 06 2022
accepted: 24 06 2022
entrez: 7 1 2023
pubmed: 8 1 2023
medline: 11 1 2023
Statut: ppublish

Résumé

In clinical trials of obsessive-compulsive disorder (OCD), clinical outcomes are generally measured using lengthy clinician-administered interviews. However, in routine clinical practice, many clinicians lack the time to administer such instruments. This study evaluated cutoffs for treatment response and remission in OCD using the self-rated Obsessive-Compulsive Inventory-Revised (OCI-R). Data from 349 patients in three clinical trials of cognitive-behavioral therapy for OCD were pooled for analysis. The OCI-R was compared to gold-standard criteria for response and remission based on the clinician-administered Yale-Brown Obsessive Compulsive Scale and the Clinical Global Impression Scale. The results showed that a ≥40% reduction on the OCI-R was the optimal cutoff for treatment response, with a sensitivity of 0.72 and a specificity of 0.79. For remission status, the optimal cutoff was ≤8 points on the OCI-R, with a sensitivity of 0.57 and specificity of 0.83. Results from additional analyses using the 12-item version of the OCI were similar. These cutoffs provide a simple and time-efficient way to help determine treatment response and remission in OCD when the administration of clinician-administered instruments is unfeasible.

Identifiants

pubmed: 36608976
pii: S0005-7894(22)00082-X
doi: 10.1016/j.beth.2022.06.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-50

Informations de copyright

Copyright © 2022 Association for Behavioral and Cognitive Therapies. Published by Elsevier Ltd. All rights reserved.

Auteurs

Oskar Flygare (O)

Karolinska Institutet and Stockholm Health Care Services. Electronic address: oskar.flygare@ki.se.

John Wallert (J)

Karolinska Institutet and Stockholm Health Care Services.

Long-Long Chen (LL)

Karolinska Institutet and Stockholm Health Care Services.

Lorena Fernández de la Cruz (L)

Karolinska Institutet and Stockholm Health Care Services.

Lina Lundström (L)

Karolinska Institutet and Stockholm Health Care Services.

David Mataix-Cols (D)

Karolinska Institutet and Stockholm Health Care Services.

Christian Rück (C)

Karolinska Institutet and Stockholm Health Care Services.

Erik Andersson (E)

Karolinska Institutet and Stockholm Health Care Services.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH